Medication adherence in outpatients with severe mental disorders relation between self-reports and serum level

Journal of Clinical Psychopharmacology

Volumn 30, Issue 2, 2010, Pages 169-175

  Jónsdóttir, Halldóra ^a,b   Opjordsmoen, Stein ^a,b   Birkenaes, Astrid B ^b,c   Engh, John A ^a,b   Ringen, Petter Andreas ^b,c   Vaskinn, Anja ^b,c   Aamo, Trond O ^d   Friis, Svein ^a,b   Andreassen, Ole A ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bipolar disorder; Medication adherence; Schizophrenia; Self report; Serum levels

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; LAMOTRIGINE; LEVOMEPROMAZINE; LITHIUM; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BIPOLAR DISORDER; DRUG BLOOD LEVEL; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AMBULATORY CARE; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; NORWAY; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; SELF CARE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77952142466     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181d2191e     Document Type: Article

References (47)

1. Weiden. DI, Glazer W. Assessment and treatment selection for "revolving door" inpatients with schizophrenia. Psychiatr Q. 1997 68: 377-392.
2. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997 23: 637-665.
3. Law MR, Soumerai SB, Ross-Degnan D, et al. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry. 2008; 69: 47-53. (Pubitemid 351281996)
4. Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiatr Scand. 1999 100: 167-175.
5. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004 161: 692-699.
6. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002 63: 892-909.
7. Lingram. R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002 105: 164-172.
8. Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. Clin Psychiatry. 2005; 66(suppl 1): 24-29. (Pubitemid 350042454)
9. Colom F, Vieta E, Tacchi MJ, et al. Identifying and improving non-adherence in bipolar disorder. Bipolar Disord. 2005; 7(suppl.5): 24-31. (Pubitemid 43013457)
10. Sajatovic M, Valenstein M, Blow FC, et al. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006; 8: 232-241. (Pubitemid 43053837)
11. Velligan. DI, Lam Y-WF, Glahn DC. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schkophr Bull. 2006 32: 724-742.
12. Awad GA. Antipsychotic medications: compliance and attitudes towards treatment. Curr Opin Psychiatry. 2004 17: 75-80.
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 353: 487-497.
14. Baumann P, Hiemke C, Ulrich S, et al. Therapeutic monitoring of psychotropic drugs an outline of the AGNP-TDM expert group consensus guideline. Ther Drug Manit. 2004; 26: 167-170. (Pubitemid 38501212)
15. Goodwin FK, Jameson KR. Manic Depressive Illness. New York: Oxford University Press; 2007.
16. Manwani SG, Szilagyi. KA, Zablotsky B, et al. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry. 2007; 68: 1172-1176. (Pubitemid 47395618)
17. Zeber JE, Copeland LA, Good CH, et al. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008; 107: 53-62. (Pubitemid 351288909)
18. Sajatovic M, Valenstein A, Blow F, et al. Treatment adherence with lithium and anticonvulsants medications among patients with bipolar disorder. Psychiatr Serv. 2007; 58: 855-863. (Pubitemid 46985180)
19. Rudd P. The measurement of compliance: medication taking. In: Krasnegor NA, Epstein LH, Johnson SB, et al, eds. Developmental Aspects of Health Compliance Behaviour. Hillsdale, NJ: Lawrence Erlbaum; 1993: 185-213.
20. Byerly MJ, Thompson A, Carmody T. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv. 2007; 58: 844-847. (Pubitemid 46985178)
21. Kennedy JS, von Moltke LL, Harmatz JS, et al. Validity of self-reports of caffeine use. J Clin Pharmacol. 1991 31: 677-680.
22. Stephenson BJ, Rowe BH, Haynes B, et al. The rational clinical examination. Is this patient taking the treatment as prescribed. JAMA. 1993 269: 2779-2781.
23. Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence. A summary of the literature. Med Care. 2004 42: 649-652.
24. Dolder CR, Lacro JP, Warren KA, et al. Brief evaluation of medication influences and beliefs. Development and testing of a brief scale for medication adherence. J Clin Psychopharmacol. 2004 24: 404-409.
25. Byerly MJ, Nakonenzy PA, Rush JA. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schkophr Res. 2008 100: 60-69.
26. Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schkophr Res. 2008 100: 53-59.
27. Velligan DI, Wang M, Diamond P, et al. Relationship among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv. 2007; 58: 1187-1192. (Pubitemid 47507958)
28. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002; 63: 384-390. (Pubitemid 34507214)
29. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels and psychiatric hospitalization. Am J Psychiatry. 2002; 159: 1927-1929. (Pubitemid 35283261)
30. Birkenees AB, Søgaard AJ, Engh JA, et al. Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. J Clin Psychiatry. 2006: 67: 425-433.
31. Spitzer RL, Williams JB, Gibbon M, et al. The structural clinical interview for DSM-III-R (SCID). I: history, rationale and description. Arch Gen Psychiatry. 1992 49: 624-629.
32. Castberg I, Skogvoll E, Spigset O. Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service. J Clin Psychiatry. 2007; 68: 1540-1545. (Pubitemid 350073402)
33. Home R, Weinman. J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002 17: 17-32.
34. Mårdby AC, Åkerlind I, Jörgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007; 69: 158-164. (Pubitemid 350051686)
35. Johnson G, Kong DCM, Thoman R, et al. Factors associated with medication nonadherence in patiente with COPD. Chest. 2005: 128: 3198-3204. (Pubitemid 41698641)
36. Bowskill R, Clatwothy J, Parham R, et al. Patients' perceptions of infomation received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord. 2007; 100: 253-257. (Pubitemid 46818443)
37. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patients beliefs and health-related behaviour. J Psychosom Res. 2005; 58: 403-415. (Pubitemid 40982202)
38. Thompson K, Kulkami J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schkophr Res. 2000; 42: 241-247. (Pubitemid 30216535)
39. Rettenbacher MA, Hofer A, Eder U, et al. Compliance in schizophrenia: psychopathology, side effects, and patients attitudes toward the illness and medication. J Clin Psychiatry. 2004 65: 211-1218.
40. Weiss KA, Smith TE, Hull JW, et al. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schkophr Bull. 2002 28: 341-349.
41. Yamada K, Watanabe K, Němoto N, et al. Prediction of medication non-compliance in outpatients with schizophrenia: a 2-year follow-up study. Psychiatr Res. 2006; 141: 61-69. (Pubitemid 43011351)
42. Garavan J, Browne S, Gervin M, et al. Compliance with neuroleptic medication in outpatients with schizophrenia; Relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry. 1998; 39: 215-219. (Pubitemid 28326194)
43. Craddock N, Owen MJ. The beginning of the end for Kraepelinian dichotomy. Br J Psychiatry. 2005 186: 364-366.
44. Cavanagh J, Smyth R, Goodwin. GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand. 2004; 109: 91-95. (Pubitemid 38186819)
45. Schumann C, Lenz G, Berghöfer A, et al. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatr Res. 1999; 89: 247-257. (Pubitemid 30053007)
46. Johnson. RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry. 1996; 153: 993-1000. (Pubitemid 26264698)
47. Keck PE, McElroy SL, Strakowski SM, et al. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull. 1997; 33: 87-91. (Pubitemid 27184199)